1Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization Classification of Neoplasms of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting -Airlie House, Virginia, November, 1997. Hematol J, 2000 ; 1:53-66.
2Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms : a proposal from the International Lymphoma Study Group. Blood, 1994 ;84 : 1361-1392.
3Judith F. Margolin, C. Philip Steuber, David G Poplaek. Acute Lymphoblastic leukemia in Principle and Practice of Pediatric Oncology, by Philip A. Pizzo, David G Poploek. 5rded. Philadelphia. New York: LWW. com, 2006, p538-590.
4Michael P. Link, howard J. Weinstein. Malignant Non-Hodgkin' s Lymphoma in Children. in Principle and Practice of Pediatric Oncology, by Philip A. Pizzo, David G Poplock. 5rded. Philadelphia. New York: LWW. com, 2006,p722-747.
5Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastie lymphoma: a BFM group report. Blood.2000 Jan 15 ;95 (2) :416-21.
6Grenzebach J, Schrappe M, Ludwig WD, et al. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy. Ann Hematol. 2001 ;80 Suppl 3 :B73-6.
7Woessmann W, Seidemann K, Mann G, The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005 Feb 1;105(3):948-58. Epub 2004 Oct 14.
8Patte C, Auperin A, Gerrard M,Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007 Apr 1 ;109 (7) :2773-80.
9Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non- Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frank-furt-Mfinster Group Trial NHL-BFM 90. Blood, 2001, 97: 3699-3706.
同被引文献11
1Al-Samawi AS,Aulaqi SM,Al-Thobhani AK.Childhood lymphomasin Yemen Clinicopathological study[J].Saudi Med J,2009,30(9):1192-1196.
2Hochberg J,Waxman IM,Kelly KM,et al.Adolescent non-Hodgkinlymphoma and Hodgkin lymphoma:State of the science[J].Br JHaematol,2009,144(1):24-40.
3Büyükpamuku M,Varan A,Akyüz C,et al.The treatment of child-hood Hodgkin lymphoma:Improved survival in a developing country[J].Acta Oncol,2009,48(1):44-51.
